Загрузка...
Cancer Site and Adverse Events Induced by Immune Checkpoint Inhibitors: A Retrospective Analysis of Real-life Experience at a Single Institution
BACKGROUND: Data on the characteristics of patients who are likely to experience adverse events, both immune-related and non-immune-related, from programmed cell death-1 (PD1) inhibitors are limited. PATIENTS AND METHODS: Data from patients who received ≥1 dose of single-agent PD1 inhibitor between...
Сохранить в:
| Опубликовано в: : | Anticancer Res |
|---|---|
| Главные авторы: | , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6886239/ https://ncbi.nlm.nih.gov/pubmed/30711957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/anticanres.13175 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|